Green Alpha Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Green Alpha Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$617K	Buy	1,180 +628	+114%	+$322K	0.42%	65
2026 Q2	$274K	Buy	552 +6	+1%	+$2.66K	0.18%	89
2026 Q1	$244K	Sell	546 -79	-13%	-$36.8K	0.24%	85
2025 Q4	$283K	Buy	+625	New	+$269K	0.26%	91
2025 Q3	–	Sell	-565	Closed	-$252K	–	110
2025 Q2	$252K	Sell	565 -103	-15%	-$47.5K	0.24%	89
2025 Q1	$324K	Sell	668 -21	-3%	-$9.79K	0.35%	80
2024 Q4	$277K	Sell	689 -129	-16%	-$59.8K	0.22%	117
2024 Q3	$380K	Sell	818 -69	-8%	-$33.1K	0.3%	102
2024 Q2	$416K	Sell	887 -118	-12%	-$51.2K	0.33%	98
2024 Q1	$420K	Sell	1,005 -8	-0.8%	-$3.38K	0.3%	108
2023 Q4	$412K	Sell	1,013 -179	-15%	-$66.1K	0.3%	117
2023 Q3	$415K	Sell	1,192 -651	-35%	-$228K	0.32%	106
2023 Q2	$649K	Buy	1,843 +252	+16%	+$84.9K	0.43%	88
2023 Q1	$501K	Sell	1,591 -45	-3%	-$13.5K	0.35%	105
2022 Q4	$472K	Sell	1,636 -16	-1%	-$4.88K	0.39%	104
2022 Q3	$478K	Buy	1,652 +6	+0.4%	+$1.73K	0.4%	111
2022 Q2	$464K	Sell	1,646 -1,189	-42%	-$318K	0.11%	129
2022 Q1	$740K	Buy	2,835 +109	+4%	+$25.9K	0.5%	83
2021 Q4	$599K	Buy	2,726 +63	+2%	+$12.3K	0.4%	100
2021 Q3	$483K	Buy	2,663 +265	+11%	+$51.7K	0.33%	118
2021 Q2	$484K	Buy	2,398 +479	+25%	+$100K	0.33%	120
2021 Q1	$412K	Buy	+1,919	New	+$422K	0.41%	89

Other funds holding VRTX

MSV

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

VWM

Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GGS

Galvin Gaustad & Stein Scottsdale, Arizona $1.33B AUM 13.15% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

LJHT

Laurie J. Hall Trustee $314M AUM 27.43% 1-Year Est. Return

CFG

Cooper Financial Group Irvine, California $1.26B AUM 21.18% 1-Year Est. Return

Green Alpha Advisors's VRTX Position: Q3 2026 in Review

Green Alpha Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 114% in Q3 2026, buying an estimated $322K and bringing the position to 1,180 shares worth $617K. The position accounts for 0.42% of the portfolio, ranked #65.

Green Alpha Advisors first reported a position in VRTX in Q1 2021 and has held it in 22 quarters since. The position peaked at $740K in Q1 2022. 66 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

Green Alpha Advisors held 1,180 shares of Vertex Pharmaceuticals worth $617K as of Q3 2026.
Green Alpha Advisors bought 628 Vertex Pharmaceuticals shares in Q3 2026, an estimated $322K.
Vertex Pharmaceuticals made up 0.42% of Green Alpha Advisors's portfolio in Q3 2026, its #65 holding.
Green Alpha Advisors first reported a position in Vertex Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
Green Alpha Advisors's Vertex Pharmaceuticals position peaked at $740K in Q1 2022.
66 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Green Alpha Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.